The exceptional team executing Cannim’s strategy have a diverse background with expertise in business, cannabis cultivation and genetics, large scale agriculture, capital markets, law and M&A, medicine, logistics and international trade. A selection of our Executive Team, Board of Directors, Incoming Board of Directors and Advisory Board, is below.
Founder and Executive Chair
John Worton is a seasoned entrepreneur and company director with extensive Australian and International experience in growth companies. A UK qualified chartered accountant and Sandhurst graduate, John’s leadership has been instrumental in four initial public offerings to a variety of industries, including OzEmail’s NASDAQ listing in 1996 while serving as the CFO.
John has held C-level positions at various companies. His business career includes roles at Qantas, Opportunity International, BMC Media, Allomak and PKF Chartered Accountants.
Chief Financial Officer
A UK Chartered Accountant with significant Financial and Commercial experience as FD/CFO with US, UK and Australian multinationals in multiple industries. In addition to his financial expertise Chris has spent many years working specifically with CEO’s and Sales teams to develop new business opportunities. Chris has also worked with UK start-ups helping them to raise investor funds and develop strategy as well as implementing management reporting and financial control.
Director of Global Operations
Lachlan has worked across a broad range of industries and has a passion for helping businesses achieve rapid and sustainable growth. After completing a Bachelor of Medical Science and a Bachelor of Business, he commenced his career in the pharmaceutical sector, working predominantly with the Novartis group. Subsequently gaining further experience across the Medical, Property, IT and Welfare industries and as a member of the Australian Institute of Company Directors, Lachlan has worked with several organisations to prosper through periods of triple-digit growth. He has developed a passion for business strategy, operational planning implementation, team development and key supply partner engagement. His companies have featured regularly in the Australian BRW Fast 100.
Director of Security and Govt. Liaison
Former Police Commissioner for Jamaica and Chief of Staff of the Jamaica Defense force. After a distinguished 38 year career in public service, the Admiral finds it ironic to be engaged in securing the crop he once sought to eradicate. H. has served on several Boards including the Marine Board, Maritime Authority, and the Caribbean Maritime Institute. He was Jamaica’s representative on the UNDCP’s Informal Correspondence Group on Maritime Cooperation and on the UNESCO Council of the Inter-Governmental Oceanographic Commission.
Sandra De Lange
Director of Regulation and Compliance
Sandra comes from a history as banking regulator/analyst. She worked for the South African Reserve Bank’s Banking Supervision Dept for 12 years. Her experience ranges from assessing the compliance of individual banks (in terms of regulatory requirements) to managing a team responsible for research and assessment of the banking sector in terms of performance and adherence to international regulatory standards. She coordinated assessments performed by institutions such as the IMF and World Bank, and worked closely with the Basel Committee.
Sales and Marketing Director
Stuart joins the Cannim team to assist in developing sales channels for Cannim products. He brings a wealth of experience in strategic sales, devising and delivering world class marketing campaigns and creating brands in new product categories - a skillset that aligns well with the contemporary world of cannabis.
A 25 year veteran of the alcohol industry, Stuart has worked on some iconic brands - Stella Artois, XXXX, Jim Beam and most recently [yellow tail], the 6th largest wine brand in the world where he was responsible for their global innovation program. Stuart’s focus will be on establishing sales channels for Cannim’s product through the value chain and developing relationships with strategic partners to co-create a series of new cannabis brands across a spectrum of categories, aimed at core global markets.
Ezzes hails from a distinguished investment career including Goldman Sachs, Thomas H. Lee Capital and Bass Investment Limited Partnership. He has served on the board of directors of a number of US and Australian companies. He served on the board of directors of OzEmail and was instrumental in its successful initial public offering on NASDAQ, as the first Australian company to directly list in the USA.
Leading M&A Lawyer
Respected Jamaican Entrepreneur
Dr. David Ostrow
As a triple Boarded (Adult Psychiatry, Addiction Medicine [ASAM] and Cannabinoid Medicine [AACM]) physician-scientist, he is currently focused on the integrated care of patients with co-morbid major psychiatric, substance use, and chronic medical conditions. This has led him to develop and evaluate Integrative, Harm-Reduction and relapse minimization treatment approaches that are both cost-effective and maximize the rehabilitation potential of these patients, rather than their criminalization, isolation and stigmatization. As a result, he realized early on in the HIV/AIDS Epidemic that cannabis was unique among popular psychoactive drugs in that it did not facilitate transmission or progression of immunodeficiency, but instead was being used by many patients to ameliorate the side effects of anti-retroviral (ARV) treatment and common symptoms related to AIDS, such as wasting and depression.
Dr Ostrow’s next career step focuses on the implementation of the CBCCERN (Community-Based Clinical Cannabis Evaluation & Research Network) and the development of the professional education and training programs and curricula for the objective and subjective data collection to be valid. Through these collaborations with clinical, research and educational/training pograms, he hopes to utilize his broad range of experience in the further development of integrative therapies for complex mental health and addiction patients, often in the context of debilitating chronic physical health conditions, that are generally not adequately responsive to currently available FDA-approved therapies, and without the severe adverse side effects of opioid dependence, addiction and overdose.
Dr. Dieter Meier
Trained neurologist and hands-on executive with extensive experience in large and small pharmaceutical companies with proven success in setting strategic direction and delivering projects. Has developed, obtained regulatory approval for, and launched significant medications. Global experience including Neuropore, Ever Neuro Pharma, Johnson and Johnson. Led cross- functional teams from preclinical to Phase 1 transition through life-cycle management in areas of Neurology, Psychiatry, Pain, Metabolic Disease and General Medicine.
Cannabis & Cultivation
Prof. Lumir Hanus
Prof. Hanuš is an expert analytic chemist and leading authority in the field of medical cannabis research. With an M.S. and Ph.D. in analytical chemistry, and a Dr.Sc. in pharmaceutical chemistry, he has been studying cannabis since the fall 1970.
Yaron has decades of experience in cultivation and processing crops for human consumption, under controlled conditions and in greenhouses, at commercial scale. For the last six years this included medicinal cannabis under license from the Ministry of Health in Israel. Yaron was the Master Grower at Tikun Olam (Israel’s largest medicinal cannabis grower) and more recently at Canndoc. He brings extensive knowledge, Israeli expertise and contacts in Medicinal Cannabis.
Director of Operations
Nadav is a businessman and agronomist. His extensive experience began in Israel and spans more than 40 years in Africa, North America & Asia. Specializing in transforming medium and large-sized farms into successful companies, Nadav has managed a 5,000-acre banana plantation for export with a staff of 2,800 persons and diversified it crops. Focuses on the establishment and improvement of farm modernization and field practices, export management, plant nutrition and irrigation systems.
Director of Global Innovation
Daniel has dual backgrounds in molecular biology and high-tech horticulture, and for the last decade has focused on the creation of 2nd generation cannabis using biotechnology. Prior to joining the Cannim team, Daniel designed and ran state-of-the-art commercial cannabis operations, plant science laboratories, and consulted for universities, hemp farms and cannabis companies in Australia, Thailand and the USA. As an Honorary Fellow at the University of Melbourne’s School of BioSciences, Daniel successfully spearheaded the development of several bio-safe agricultural products and novel hemp-derived nutraceuticals.
Daniel brings a wealth of knowledge to the team surrounding outdoor growing, West Coast America greenhouse design, aquaponics, aeroponics and hydroponics technology, as well as direct access to current peer reviewed research and recommendations in each of these methods. While Israeli technology remains at the forefront of Cannim’s cultivation practices, Daniel will assist the team in trialling additional best-in-class methodologies over the coming months to ensure their modus operandi takes advantage of the latest best-practice technology in this evolving industry.